To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Novartis researchers aim to quash inflammation to treat chronic disease.

Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.

Experts call for significant changes to facilitate the discovery of new treatments.